EP Patent

EP1638505B1 — Amphiphilic pyridinium compounds, method of making and use thereof

Assigned to Henry M Jackson Foundation for Advancedment of Military Medicine Inc · Expires 2012-04-25 · 14y expired

What this patent protects

The present invention is directed to the amphiphilic pyridinium compounds, such as for suppressing IL-8 secretion and production. The present invention further provides methods of making and using such compounds for the treatment of the IL-8 related diseases, such as cystic fibro…

USPTO Abstract

The present invention is directed to the amphiphilic pyridinium compounds, such as for suppressing IL-8 secretion and production. The present invention further provides methods of making and using such compounds for the treatment of the IL-8 related diseases, such as cystic fibrosis.

Drugs covered by this patent

Patent Metadata

Patent number: EP1638505B1
Jurisdiction: EP
Classification: —
Expires: 2012-04-25
Drug substance claim: No
Drug product claim: No
Assignee: Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.